14 November 2017

Funding in the UK Life Science sector

The continued growth of the UK Life Science sector was confirmed earlier this year at the Future of Healthcare Investor Forum hosted by the London Stock Exchange.

£1.96bn was raised in life science initial public and further offerings in 2016, bringing the total since 2014 close to £6bn –an historic 3-year peak in life science funding in the UK. Further to this, early stage investment into the UK’s most promising life science companies more than tripled in 2016, and first quarter reports for 2017 indicated that this trend will continue.

The Government is clearly mindful of the role that the Life Science sector plays in the UK economy as it plans the UK’s future outside of the European Union. It confirmed, after the Brexit referendum, that whilst Britain remains part of the EU, the Treasury will underwrite research projects receiving EU funding even when projects continue beyond the UK’s departure from the EU. These include universities participating in Horizon 2020, the EU’s research and innovation programme that is making nearly €80bn of funding available between 2013 and 2020.

To read the full article please click below.